Page last updated: 2024-08-23

substance p and Astrocytoma, Grade IV

substance p has been researched along with Astrocytoma, Grade IV in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (11.76)18.2507
2000's1 (5.88)29.6817
2010's6 (35.29)24.3611
2020's8 (47.06)2.80

Authors

AuthorsStudies
Belchior, A; Campello, MPC; Carvalho, J; Cruz, C; D'Onofrio, A; Di Maria, S; Marques, A; Marques, F; Mendes, C; Oliveira, MC; Paulo, A; Pinto, C; Raposinho, P; Silva, F1
Assaran Darban, R; Hashemy, SI; Javid, H; Rezaei, S1
Del Carmen Silva-Lucero, M; Mora-Escobedo, R; Pérez-Cruz, C; Pérez-Grijalva, B; Ramón-Gallegos, E; Sampedro, EC; Tornero-Martínez, A1
Argüelles, S; Ayala, A; Coveñas, R; Medina, R; Muñoz, M; Muñoz, MF; Rosso, M1
Aldardeir, N; Baeesa, S; Bahakeem, B; Bamaga, A; Faizo, E; Fawzy Halawa, T; Hakamy, S; Hassan, A; Katib, Y; Kurdi, M; Maghrabi, Y; Mehboob, R; Moshref, R; Nasief, H; Rasool, S; Saeedi, R; Tanvir, I; Waseem, H1
Bruchertseifer, F; Koziara, H; Królicki, L; Kuliński, R; Kunikowska, J; Merlo, A; Morgenstern, A; Pawlak, D; Rola, R1
Inada, E; Iseki, M; Kumakura, S; Nagaoka, I; Someya, A; Yamaguchi, K; Yamazaki, S1
Afshari, AR; Javid, H; Karkon-Shayan, S; Mollazadeh, H; Motamed-Sanaye, A; Radvar, S; Sabri, H; Sahebkar, A; Sathyapalan, T; Soltani, A1
Inada, E; Iseki, M; Kumakura, S; Nagaoka, I; Someya, A; Yamaguchi, K1
Apostolidis, C; Bruchertseifer, F; Jakuciński, M; Koziara, H; Królicki, B; Krolicki, L; Kunikowska, J; Merlo, A; Mirzadeh, S; Morgenstern, A; Pawlak, D; Rola, R1
Bauman, A; Cordier, D; Gerber, A; Hutter, G; Kluba, C; Mariani, L; Mindt, TL1
Liang, R; Ma, Y; Ni, J; Song, J; Wang, R; Wei, X; Zhang, L; Zhang, W; Zhang, Y1
Inada, E; Kumakura, S; Murakami, T; Nagaoka, I; Someya, A; Yamaguchi, K1
Akazawa, T; Cox, EA; Goldsmith, LE; Kwatra, MM; Kwatra, SG; Richardson, MD; Sampson, JH1
Cordier, D; Forrer, F; Kneifel, S; Mäcke, H; Mariani, L; Merlo, A; Müller-Brand, J; Sailer, M1
Akiyama, M; DiMaggio, DA; Hirai, Y; Inoue, A; Krause, JE; Kuroyanagi, N; Nakata, Y; Nishio, H; Ogo, H1
Kettenmann, H; Labrakakis, C; Möller, T; Patt, S; Weydt, P1

Trials

1 trial(s) available for substance p and Astrocytoma, Grade IV

ArticleYear
Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P--results from a phase I study.
    Journal of neuro-oncology, 2010, Volume: 100, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Diagnostic Imaging; Female; Follow-Up Studies; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Neoadjuvant Therapy; Organometallic Compounds; Radiopharmaceuticals; Substance P

2010

Other Studies

16 other study(ies) available for substance p and Astrocytoma, Grade IV

ArticleYear
Radiolabeled Gold Nanoseeds Decorated with Substance P Peptides: Synthesis, Characterization and In Vitro Evaluation in Glioblastoma Cellular Models.
    International journal of molecular sciences, 2022, Jan-06, Volume: 23, Issue:2

    Topics: Cell Line, Tumor; Endocytosis; Glioblastoma; Gold; Humans; Metal Nanoparticles; Models, Biological; Peptides; Radiopharmaceuticals; Serum Albumin; Spectrophotometry, Ultraviolet; Substance P; Transferrin

2022
The Therapeutic Potential of Aprepitant in Glioblastoma Cancer Cells through Redox Modification.
    BioMed research international, 2022, Volume: 2022

    Topics: Antioxidants; Aprepitant; Cell Line, Tumor; Glioblastoma; Humans; Neurokinin-1 Receptor Antagonists; Oxidation-Reduction; Reactive Oxygen Species; Receptors, Neurokinin-1; Substance P

2022
Aloe vera and Fermented Extracts Exhibit an Anti-Inflammatory Effect on Human Glioblastoma/Astrocytoma U373 MG Cells.
    Plant foods for human nutrition (Dordrecht, Netherlands), 2022, Volume: 77, Issue:1

    Topics: Aloe; Anti-Inflammatory Agents; Astrocytoma; Glioblastoma; Humans; Interleukin-6; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Polysaccharides; Substance P

2022
The Neurokinin-1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target for Treating Glioblastoma.
    BioMed research international, 2022, Volume: 2022

    Topics: Glioblastoma; Glioma; Humans; Neurokinin-1 Receptor Antagonists; Protein Isoforms; Receptors, Neurokinin-1; RNA, Small Interfering; Substance P

2022
Immunolocalization of neurokinin 1 receptor in WHO grade 4 astrocytomas, oral squamous cell and urothelial carcinoma.
    Folia neuropathologica, 2022, Volume: 60, Issue:2

    Topics: Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Epithelial Cells; Glioblastoma; Humans; Mouth Neoplasms; Receptors, Neurokinin-1; Substance P; Urinary Bladder Neoplasms; World Health Organization

2022
Locoregional Treatment of Glioblastoma With Targeted α Therapy: [ 213 Bi]Bi-DOTA-Substance P Versus [ 225 Ac]Ac-DOTA-Substance P-Analysis of Influence Parameters.
    Clinical nuclear medicine, 2023, May-01, Volume: 48, Issue:5

    Topics: Adult; Brain Neoplasms; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Middle Aged; Substance P

2023
Yokukansan, a Japanese Herbal Medicine, Suppresses Substance PInduced Production of Interleukin-6 and Interleukin-8 by Human U373 MG Glioblastoma Astrocytoma Cells.
    Endocrine, metabolic & immune disorders drug targets, 2020, Volume: 20, Issue:7

    Topics: Anti-Inflammatory Agents; Astrocytoma; Brain Neoplasms; Cell Line, Tumor; Drugs, Chinese Herbal; Glioblastoma; Herb-Drug Interactions; Herbal Medicine; Humans; Interleukin-6; Interleukin-8; Japan; Neuritis; Neuroimmunomodulation; Neuroprotective Agents; Signal Transduction; Substance P

2020
Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme.
    Current medicinal chemistry, 2021, Volume: 28, Issue:24

    Topics: Apoptosis; Glioblastoma; Humans; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P

2021
Anti‑inflammatory actions of gabapentin and pregabalin on the substance P‑induced mitogen‑activated protein kinase activation in U373 MG human glioblastoma astrocytoma cells.
    Molecular medicine reports, 2017, Volume: 16, Issue:5

    Topics: Amines; Anti-Inflammatory Agents; Astrocytoma; Cell Line, Tumor; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Glioblastoma; Humans; Interleukin-6; Interleukin-8; MAP Kinase Signaling System; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pregabalin; Receptors, Neurokinin-1; Substance P

2017
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9

    Topics: Adult; Bismuth; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radioisotopes; Substance P; Survival Analysis; Tissue Distribution; Young Adult

2018
Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy.
    Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:5

    Topics: Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Molecular Targeted Therapy; Protein Isoforms; Receptors, Neurokinin-1; Substance P

2014
Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery.
    Journal of peptide science : an official publication of the European Peptide Society, 2014, Volume: 20, Issue:10

    Topics: Acylation; Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Chlorocebus aethiops; COS Cells; DNA Replication; Female; Genetic Therapy; Glioblastoma; Humans; Plasmids; Protein Sorting Signals; Protein Transport; Recombinant Proteins; Substance P; Transfection; Uterine Cervical Neoplasms

2014
Ketamine suppresses the substance P-induced production of IL-6 and IL-8 by human U373MG glioblastoma/astrocytoma cells.
    International journal of molecular medicine, 2017, Volume: 39, Issue:3

    Topics: Astrocytoma; Cell Line, Tumor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glioblastoma; Humans; Interleukin-6; Interleukin-8; Ketamine; MAP Kinase Signaling System; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Substance P

2017
A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas.
    Journal of neurochemistry, 2009, Volume: 109, Issue:4

    Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Culture Media, Conditioned; Dose-Response Relationship, Drug; Glioblastoma; Humans; Immunohistochemistry; Neurokinin-1 Receptor Antagonists; Oncogene Protein v-akt; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Neurokinin-1; Substance P

2009
Human astrocytoma cells (U-87 MG) exhibit a specific substance P binding site with the characteristics of an NK-1 receptor.
    Journal of neurochemistry, 1996, Volume: 67, Issue:5

    Topics: Astrocytoma; Binding Sites; Binding, Competitive; Cations, Monovalent; Cell Line; Exons; Glioblastoma; Guanine Nucleotides; Guanosine Triphosphate; Humans; Kinetics; Lectins; Receptors, Neurokinin-1; RNA, Antisense; RNA, Complementary; RNA, Messenger; Substance P; Tritium; Tumor Cells, Cultured

1996
Neuroligand-triggered calcium signalling in cultured human glioma cells.
    Neuroscience letters, 1997, Jun-06, Volume: 228, Issue:2

    Topics: Adenosine Triphosphate; Adrenergic alpha-Agonists; Angiotensin II; Bradykinin; Calcium; Fluorescent Dyes; Glioblastoma; Glucose; Histamine; Humans; Neurotransmitter Agents; Norepinephrine; Oligodendroglioma; Potassium; Serotonin; Signal Transduction; Substance P; Tumor Cells, Cultured; Vasoconstrictor Agents

1997